Compare Adaptive Biotechnologies Corp (ADPT) vs Aehr Test Systems (AEHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Aehr Test Systems — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Aehr Test Systems trades at $119.96 (market cap $3.82B). The key difference: Adaptive Biotechnologies Corp and Aehr Test Systems are close in size by market cap. Which is the better fit depends on your goals.
| ADPT | AEHR | |
|---|---|---|
Market Cap | $4.04B | $3.82B |
Sector | Health | Technology |
52-Week High | $25.45 | $117.18 |
52-Week Low | $12.30 | $17.38 |
Enterprise Value | $4.10B | $3.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →
